Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |